
Sun Pharmaceutical Industries Share Price Today: Should You Buy or Not?
Updated: 27 May 2026 • 6:33 pm
Posted by:

Sun Pharmaceutical Industries share price today is Rs 1847.5, having gained 0.36 percent from its previous close of Rs 1840.8 in today’s session on NSE. The Pharmaceuticals company trades under the symbol SUNPHARMA with a market capitalisation of Rs 4,44,000 Cr. With a day high of Rs 1882.0 and a low of Rs 1830.0, investor interest in Sun Pharmaceutical Industries is positive heading into the close. The central question for investors is whether Sun Pharmaceutical Industries share price today offers a buying opportunity worth acting on.
Click Here – Get Free Investment Predictions on Univest
Sun Pharmaceutical Industries Company Overview
India’s largest pharmaceutical company and a top-5 global specialty generic firm, with strong presence in US generics, branded generics and specialty therapies.
| Parameter | Details (May 27, 2026) |
|---|---|
| NSE Symbol | SUNPHARMA |
| Sector | Pharmaceuticals |
| CMP (Live) | Rs 1847.5 |
| Today’s High | Rs 1882.0 |
| Today’s Low | Rs 1830.0 |
| Previous Close | Rs 1840.8 |
| Market Cap | Rs 4,44,000 Cr |
Sun Pharmaceutical Industries Share Price Today: Key Levels and Recent Performance
Sun Pharmaceutical Industries share price today at Rs 1847.5 has gained 0.36 percent from yesterday’s close of Rs 1840.8. Intraday trading saw a range of Rs 1830.0 to Rs 1882.0, indicating active buying interest with volume-backed momentum. The day range gives investors reference points for entry and exit decisions on the stock.
At the current market cap of Rs 4,44,000 Cr, Sun Pharmaceutical Industries is an established player in the Pharmaceuticals space. Investors tracking Sun Pharmaceutical Industries share price today should watch the intraday high of Rs 1882.0 as immediate resistance and today’s low of Rs 1830.0 as near-term support before making investment decisions.
Sun Pharmaceutical Industries Financial Performance and Business Update
Sun Pharmaceutical Industries Revenue and Earnings Trajectory
Sun Pharmaceutical Industries has been building its revenue base through its core Pharmaceuticals business. The company’s earnings profile is shaped by demand trends in its primary markets, pricing dynamics and operating leverage as volumes scale. Investors tracking Sun Pharmaceutical Industries share price today should review the latest quarterly results for revenue growth, EBITDA margin trends and PAT performance to assess earnings momentum.
Balance Sheet and Cash Flow Indicators
Balance sheet quality including debt levels, working capital efficiency and free cash flow generation are key metrics for evaluating Sun Pharmaceutical Industries as a long-term investment. Companies in the Pharmaceuticals sector with improving return on equity and manageable debt-to-equity ratios tend to sustain long-term price appreciation and deserve premium valuations.
Management Guidance and Sector Positioning
Management commentary on order book, revenue guidance and capacity plans provides the clearest forward indicator for Sun Pharmaceutical Industries share price today’s fundamental trajectory. Sector tailwinds from India’s economic growth, infrastructure investment and policy support for the Pharmaceuticals sector provide a favourable macro backdrop for the company’s medium-term performance.
Reasons to Consider Buying Sun Pharmaceutical Industries Share Today
US Generic Market Opportunity
The US is the world’s largest generic pharmaceutical market. Indian pharma companies with FDA-approved facilities and complex generic pipelines are well positioned.
Domestic Branded Generic Growth
India’s domestic formulations market is growing at 8 to 12 percent annually, driven by increasing healthcare penetration and affordability.
Biosimilars Pipeline Potential
Companies investing in biosimilars have significant upside potential as several blockbuster biologics lose patent protection.
API Self-Reliance Drive
India’s focus on reducing API import dependence from China creates structural demand for domestic API manufacturers.
Key Risks Before Buying Sun Pharmaceutical Industries Share Today
US FDA Regulatory Risk
Adverse observations or warning letters from the US FDA can severely impact revenues from the key US market.
US Generic Price Erosion
The US generics market is highly competitive with accelerating price erosion. Revenue from specific molecules can decline sharply.
API Input Cost Volatility
Pharma companies relying on imported APIs from China face supply disruption and cost volatility risks.
Technical View on Sun Pharmaceutical Industries Share Price Today
Sun Pharmaceutical Industries share price today at Rs 1847.5 is trading above its previous close, suggesting near-term buying momentum. The intraday high of Rs 1882.0 serves as immediate resistance for bulls, while the day low of Rs 1830.0 provides the first technical support level to watch. A sustained close above today’s high could trigger further upside momentum.
Investors should track key moving averages including the 20-day, 50-day and 200-day SMA relative to Sun Pharmaceutical Industries share price today to assess the broader trend direction. RSI and volume indicators alongside price action will help determine whether the current move has conviction.
Check Sun Pharmaceutical Industries live price and fundamentals on the Univest Screener
Should You Buy Sun Pharmaceutical Industries Share Today?
Sun Pharmaceutical Industries share price today at Rs 1847.5 presents a case that requires balancing sector growth potential against stock-specific valuation and risk factors. The Pharmaceuticals sector is showing positive momentum and Sun Pharmaceutical Industries is positioned within it with improving momentum and institutional interest. Long-term investors with a 2 to 3 year horizon may find merit in the stock on meaningful dips, while short-term traders should define clear entry and exit levels based on technical analysis.
Any investment decision on Sun Pharmaceutical Industries share price today should be preceded by a thorough review of the latest financials, sector outlook and portfolio fit. Investors are strongly advised to consult a SEBI-registered financial advisor before making any investment decision.
Download the Univest iOS App or Univest Android App to track Sun Pharmaceutical Industries share price today and get daily stock research.
Conclusion
Sun Pharmaceutical Industries share price today at Rs 1847.5 reflects a company with a meaningful presence in India’s Pharmaceuticals sector. The structural growth drivers for the sector, combined with Sun Pharmaceutical Industries’s competitive positioning, make it a name worth tracking for long-term investors. However, valuation discipline and awareness of sector-specific risks are essential before committing capital at current levels. Monitor quarterly earnings, management commentary and sector-level developments to make informed decisions about Sun Pharmaceutical Industries share price today.
Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice.
Frequently Asked Questions on Sun Pharmaceutical Industries Share Price Today
What is Sun Pharmaceutical Industries share price today?
Ans. Sun Pharmaceutical Industries share price today is Rs 1847.5 as of May 27, 2026, with an intraday high of Rs 1882.0 and a low of Rs 1830.0. The stock has gained 0.36 percent from its previous close of Rs 1840.8. It trades on NSE under the symbol SUNPHARMA in the Pharmaceuticals sector.
Should I buy Sun Pharmaceutical Industries share today?
Ans. Sun Pharmaceutical Industries share price today at Rs 1847.5 requires careful analysis before investing. Consider the company’s Pharmaceuticals sector positioning, earnings trajectory and valuation relative to peers. Long-term investors may consider accumulating on dips while short-term traders should use defined stop-losses. Always consult a SEBI-registered financial advisor before investing.
What is the sector of Sun Pharmaceutical Industries?
Ans. Sun Pharmaceutical Industries belongs to the Pharmaceuticals sector and trades on NSE under symbol SUNPHARMA with a market capitalisation of Rs 4,44,000 Cr. India’s largest pharmaceutical company and a top-5 global specialty generic firm, with strong presen
What is Sun Pharmaceutical Industries share price target?
Ans. Share price targets for Sun Pharmaceutical Industries depend on earnings growth, sector tailwinds and valuation re-rating potential in the Pharmaceuticals space. Investors should track quarterly earnings and sector-level developments to assess price target milestones. Use the Univest Screener for updated analyst targets and research on Sun Pharmaceutical Industries share price today.
What is the market cap of Sun Pharmaceutical Industries today?
Ans. The market capitalisation of Sun Pharmaceutical Industries is approximately Rs 4,44,000 Cr as of May 27, 2026. The company trades on NSE under symbol SUNPHARMA in the Pharmaceuticals sector.
What are the key risks in Sun Pharmaceutical Industries share?
Ans. Key risks for Sun Pharmaceutical Industries include us fda regulatory risk, us generic price erosion, and api input cost volatility. Investors should carefully evaluate these risk factors alongside the growth potential before investing in Sun Pharmaceutical Industries share price today.
How to buy Sun Pharmaceutical Industries shares?
Ans. You can buy Sun Pharmaceutical Industries shares by opening a demat and trading account with a SEBI-registered broker. Search for NSE symbol SUNPHARMA, check Sun Pharmaceutical Industries share price today, and place a buy order at market or limit price. The Univest app provides a convenient platform to track Sun Pharmaceutical Industries live price.
Where can I track Sun Pharmaceutical Industries share price live?
Ans. You can track Sun Pharmaceutical Industries share price today live on NSE under ticker SUNPHARMA. The Univest Screener provides real-time data, fundamentals, FII and DII flows, and research for Sun Pharmaceutical Industries. The Univest app also delivers daily stock recommendations and Pharmaceuticals sector analysis.
Recent Articles
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Polycab India Share Price Today: Should You Buy or Not?
Sansera Engineering Share Price Today: Should You Buy or Not?
Anand Rathi Wealth Share Price Today: Should You Buy or Not?
NTPC Ltd Share Price Today: Should You Buy or Not?
Popular this week
Polycab India Share Price Today: Should You Buy or Not?
Sansera Engineering Share Price Today: Should You Buy or Not?
Anand Rathi Wealth Share Price Today: Should You Buy or Not?
NTPC Ltd Share Price Today: Should You Buy or Not?

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas





